1. A matching-adjusted indirect treatment comparison (MAIC) of daratumumab–bortezomib–melphalan–prednisone (D-VMP) versus lenalidomide–dexamethasone continuous (Rd continuous), lenalidomide–dexamethasone 18 months (Rd 18), and melphalan–prednisone–thalidomide (MPT). Issue 3 (23rd February 2020) Authors: Dimopoulos, Meletios A.; Cavo, Michele; Mateos, Maria-Victoria; Facon, Thierry; Heeg, Bart; van Beekhuizen, Sophie; Gebregergish, Samron B.; Nair, Sandhya; Pisini, Marta; Lam, Annette; Slavcev, Mary Journal: Leukemia & lymphoma Issue: Volume 61:Issue 3(2020) Page Start: 714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma. Issue 1 (January 2015) Authors: Orlowski, Robert Z.; Gercheva, Liana; Williams, Cathy; Sutherland, Heather; Robak, Tadeusz; Masszi, Tamás; Goranova‐Marinova, Vesselina; Dimopoulos, Meletios A.; Cavenagh, James D.; Špička, Ivan; Maiolino, Angelo; Suvorov, Alexander; Bladé, Joan; Samoylova, Olga; Puchalski, Thomas A.; Reddy, Manj... Journal: American journal of hematology Issue: Volume 90:Issue 1(2015:Jan.) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma. (7th January 2013) Authors: Petrucci, Maria T.; Giraldo, Pilar; Corradini, Paolo; Teixeira, Adriana; Dimopoulos, Meletios A.; Blau, Igor W.; Drach, Johannes; Angermund, Ralf; Allietta, Nathalie; Broer, Esther; Mitchell, Vivien; Bladé, Joan Journal: British journal of haematology Issue: Volume 160:Number 5(2013:Mar.) Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A review of the venous thrombotic issues associated with multiple myeloma. Issue 7 (2nd July 2016) Authors: Fotiou, Despina; Gerotziafas, Grigoris; Kastritis, Efstathios; Dimopoulos, Meletios A.; Terpos, Evangelos Journal: Expert review of hematology Issue: Volume 9:Issue 7(2016) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Issue 7 (July 2022) Authors: Trougakos, Ioannis P.; Terpos, Evangelos; Alexopoulos, Harry; Politou, Marianna; Paraskevis, Dimitrios; Scorilas, Andreas; Kastritis, Efstathios; Andreakos, Evangelos; Dimopoulos, Meletios A. Journal: Trends in molecular medicine Issue: Volume 28:Issue 7(2022) Page Start: 542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low‐dose dexamethasone: A pooled analysis. (14th June 2017) Authors: Moreau, Philippe; Dimopoulos, Meletios A.; Richardson, Paul G.; Siegel, David S.; Cavo, Michele; Corradini, Paolo; Weisel, Katja; Delforge, Michel; O'Gorman, Peter; Song, Kevin; Chen, Christine; Bahlis, Nizar; Oriol, Albert; Hansson, Markus; Kaiser, Martin; Anttila, Pekka; Raymakers, Reinier; Joa... Journal: European journal of haematology Issue: Volume 99:Number 3(2017) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine. Issue 7 (24th April 2021) Authors: Terpos, Evangelos; Trougakos, Ioannis P.; Apostolakou, Filia; Charitaki, Ioanna; Sklirou, Aimilia D.; Mavrianou, Nefeli; Papanagnou, Eleni‐Dimitra; Liacos, Christine‐Ivy; Gumeni, Sentiljana; Rentziou, Gianna; Korompoki, Eleni; Papassotiriou, Ioannis; Dimopoulos, Meletios A. Journal: American journal of hematology Issue: Volume 96:Issue 7(2021) Page Start: E257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Alcohol consumption and risk of hematological malignancies: A meta‐analysis of prospective studies. Issue 3 (30th March 2018) Authors: Psaltopoulou, Theodora; Sergentanis, Theodoros N.; Ntanasis‐Stathopoulos, Ioannis; Tzanninis, Ioannis‐Georgios; Tsilimigras, Diamantis I.; Dimopoulos, Meletios A. Journal: International journal of cancer Issue: Volume 143:Issue 3(2018) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Alcohol intake, alcoholic beverage type and multiple myeloma risk: a meta-analysis of 26 observational studies. Issue 5 (May 2015) Authors: Psaltopoulou, Theodora; Sergentanis, Theodoros N.; Sergentanis, Ioannis N.; Karadimitris, Anastasios; Terpos, Evangelos; Dimopoulos, Meletios A. Journal: Leukemia & lymphoma Issue: Volume 56:Issue 5(2015:May) Page Start: 1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma. (January 2019) Authors: Dimopoulos, Meletios A.; Grosicki, Sebastian; Jędrzejczak, Wiesław W.; Nahi, Hareth; Gruber, Astrid; Hansson, Markus; Gupta, Neeraj; Byrne, Catriona; Labotka, Richard; Teng, Zhaoyang; Yang, Huyuan; Grzasko, Norbert; Kumar, Shaji Journal: European journal of cancer Issue: Volume 106(2019) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗